Translation of the mouse protamine 1 (Prm-1) mRNA is repressed for several days during male germ cell differentiation. With the hope of cloning genes that regulate the translational repression of Prm-1, we screened male germ cell cDNA expression libraries with the 3 untranslated region of the Prm-1 RNA. From this screen we obtained two independent clones that encode Prbp, a Prm-1 RNA-binding protein. Prbp contains two copies of a double-stranded-RNA-binding domain. In vitro, the protein binds to a portion of the Prm-1 3 untranslated region previously shown to be sufficient for translational repression in transgenic mice, as well as to poly(I) ⅐ poly(C). Prbp protein is present in multiple forms in cytoplasmic extracts prepared from wild-type mouse testes and is absent from testes of germ cell-deficient mouse mutants, suggesting that Prbp is restricted to the germ cells of the testis. Immunocytochemical localization confirmed that Prbp is present in the cytoplasmic compartment of late-stage meiotic cells and haploid round spermatids. Recombinant Prbp protein inhibits the translation of multiple mRNAs in a wheat germ lysate, suggesting that Prbp acts to repress translation in round spermatids. While this protein lacks complete specificity for Prm-1-containing RNAs in vitro, the properties of Prbp are consistent with it acting as a general repressor of translation.
Translational regulation is a common mechanism of gene regulation in gametogenesis and in early embryonic development (9, 40) . One reason for translational control is that it permits changes in protein levels to occur in the absence of new transcription; this is a necessity in murine spermatogenesis, since transcription ceases well before most of the dramatic morphological changes that accompany spermatid differentiation occur (21, 37) . Genes known to be under translational control during murine spermatogenesis include those involved in mediating nuclear condensation, which occurs in the final stages of spermiogenesis. These include the genes for the two transition proteins, TP1 and TP2 (25, 52) , and the protamines, Prm-1 (1, 24) and Prm-2 (18) . Translational repression of Prm-1 mRNA is essential for normal spermatid differentiation, since premature translation of Prm-1 mRNA leads to dominant male sterility in transgenic mice (30) .
Despite the widespread occurrence of translational regulation in many developmental processes, relatively little is known about the molecular mechanisms which regulate mRNA behavior. However, a major discovery in recent years has been the demonstration that 3Ј untranslated regions (3Ј UTRs) play a critical role in regulating mRNA transport, localization, stabilization, and translation (reviewed in references 8 and 19) . Further understanding of how 3Ј UTRs mediate such diverse effects on RNA behavior necessitates the identification of molecules within the cell that bind to the 3Ј end of the message.
Sequences contained within the 3Ј UTR of the Prm-1 mRNA are required for its translational repression in round spermatids (4) . As little as 62 nucleotides (nt) of the Prm-1 3Ј UTR is able to confer a translational delay on a heterologous reporter human growth hormone mRNA (hGH mRNA) in round spermatids, whereas the 3Ј UTR of hGH, or the 3Ј-most 23 nt of the Prm-1 3Ј UTR, is not able to confer such a delay (3, 4) . The mechanism by which the Prm-1 3Ј UTR inhibits its translation is unknown. Presumably proteins or antisense RNAs interact with sequences in the 3Ј-most 62 nt of the 3Ј UTR and prevent translation initiation from occurring at the 5Ј end of the message. The involvement of antisense RNA in mediating translational control via the 3Ј UTR has recently been demonstrated for the lin-14 mRNA in Caenorhabditis elegans (30a, 51a) . We have been unable to detect the presence of Prm-1 3Ј UTR antisense RNAs in total testis RNA preparations by Northern (RNA) blotting (29a), suggesting that antisense RNAs are not involved in Prm-1 translational repression.
Proteins that bind to the 3Ј UTRs of Prm-1 and Prm-2 RNAs have been previously identified. Kwon and Hecht (27a, 27b) have described two regions in the 3Ј UTRs of Prm-1 and Prm-2 mRNA, the Y and H boxes, that interact with proteins present in testis extracts and have shown that the Y box in Prm-2 can be UV cross-linked to a protein of 18 kDa. We (12a) have characterized proteins of 48 and 50 kDa that are present in the cytoplasmic fraction of pachytene spermatocytes and round spermatids and have shown that they bind to a conserved sequence in the Prm-1 and Prm-2 3Ј UTRs. Surprisingly, neither the Y box nor the H box (27a), nor the binding site for the 48-and 50-kDa proteins (12a) , is contained within the minimal 62-nt region of the Prm-1 3Ј UTR RNA that is sufficient for translational repression in transgenic mice (3) . These observations suggest that there may be redundancy in the cis-acting elements that control the translational repression of Prm-1 mRNA or that the proteins and the binding sites thus far identified are involved in other aspects of Prm-1 and Prm-2 RNA behavior besides their translational repression. We have recently shown that mRNAs that contain the binding site for the 48-and 50-kDa proteins and that lack all but the 3Ј-most 23 nt of the Prm-1 3Ј UTR are also under translational repression in transgenic mice (unpublished data). Thus, two different re-gions of the Prm-1 3Ј UTR are sufficient for translational repression in vivo, demonstrating that there is redundancy in the cis-acting elements that mediate its translational repression.
In an attempt to clone cDNAs that encode Prm-1 3Ј UTR RNA-binding proteins, we screened germ cell cDNA libraries with the 3Ј UTR of Prm-1 RNA. We have recently described two of the genes isolated from this screen. One of these genes, Spnr, encodes an RNA-binding protein that is localized to a spermatid-specific microtubule array called the manchette, (15) . Numbers refer to amino acid position. Boxes indicate the positions of the conserved dsRNA-binding domains (14) . A 24-amino-acid peptide that is sufficient for RNA binding is indicated by the underline (14) .
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suggesting that it is involved in the transport and translational activation of spermatid mRNAs (46) . The product of the second gene, Tenr, also encodes an RNA-binding protein, and it is localized in a lattice-like network within the spermatid nucleus (45) . The Tenr protein contains a region with similarity to known double-stranded RNA (dsRNA) adenine deaminases, suggesting that it may function in the editing of spermatidspecific RNAs. We report here the cloning and characterization of a third gene from this screen, whose product has the properties expected of a protein that represses the translation of numerous mRNAs, including the Prm-1 message, in the testis.
MATERIALS AND METHODS
Mice. B6SJLF 1 /J and B6CBAF 1 /J mice, used for the preparation of tissue protein extracts, RNA, or testis sections, were obtained from the Jackson Laboratory (Bar Harbor, Maine).
cDNA cloning. Mouse mixed germ cell, pachytene spermatocyte, and round spermatid cDNA expression libraries were screened as described previously for DNA-binding proteins (47, 51) , except that filters were probed with RNAs labeled with either digoxigenin-UTP (Boehringer Mannheim, Indianapolis, Ind.) (100 ng/ml) (primary screen) or [␣-
32 P]UTP (1 ϫ 10 6 to 3 ϫ 10 6 cpm/ml) (secondary and tertiary screens) in 0.25% nonfat milk in binding buffer. The probes, either the 156-nt full-length Prm-1 3Ј UTR RNA or the 145-nt full-length hGH 3Ј UTR RNA, were prepared by in vitro transcription with SP6 or T7 RNA polymerase. After extensive washing in binding buffer, positive phage plaques were detected by autoradiography or by immunological reaction with an antidigoxigenin antibody conjugated to alkaline phosphatase according to the protocol supplied by the manufacturer (Genius nucleic acid detection kit [Boehringer Mannheim]).
Seven overlapping restriction fragments of the Prbp cDNA were gel isolated and subcloned into the pBluescript KS(Ϫ) vector (Stratagene, La Jolla, Calif.) for sequencing. Double-stranded DNA templates were sequenced by the dideoxy chain termination method (43) with a Sequenase kit (U.S. Biochemical, Cleveland, Ohio). Databases were searched by using the Intelligenetics suite (Intelligenetics, Mountain View, Calif.) and Blast (National Center for Biotechnology Information, Bethesda, Md.) programs.
RNA analysis. Total RNA was isolated from dissected tissues as described previously (5) . After being cooled on ice for 15 min, samples were microcentrifuged for 20 min at 4ЊC. RNA in the aqueous phase was precipitated with 1 volume of isopropanol. Following centrifugation, the RNA pellet was dissolved in 10 mM Tris-HCl (pH 7.5)-5 mM EDTA-1% sodium dodecyl sulfate (SDS), extracted with a 4:1 mixture of chloroform and 1-butanol, and precipitated with 2 volumes of absolute ethanol. RNA samples were separated on a 1.5% agarose gel containing 2.2 M formaldehyde, transferred to a nitrocellulose membrane, fixed by being baked at 80ЊC, and hybridized at 45ЊC in 50% formamide-5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-50 mM NaPO 4 (pH 6.5)-250 g of single-stranded DNA per ml-1ϫ Denhardt's solution-0.5% SDS-6.25% dextran sulfate with ␣-32 P-labeled probes prepared from cDNA by random hexamer labeling. The blot was washed at a final stringency of 0.1ϫ SSC and 0.5% SDS at 50ЊC.
Preparation of tissue extracts. Total cell extracts were prepared as described previously (42) with some modifications. Briefly, tissues were dissected and homogenized in 5 volumes of triple-detergent lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate, and protease inhibitors [1 g of aprotinin per ml, 1 mM benzamidine, 0.5 g of leupeptin per ml, 1 g of pepstatin A per ml, 0.5 mM phenylmethylsulfonyl fluoride]) by 20 to 30 strokes of a Dounce homogenizer. After incubation for 30 min on ice, the homogenates were centrifuged at 12,000 ϫ g for 2 min at 4ЊC. Each supernatant was aliquoted, quickly frozen in liquid N 2 , and stored at Ϫ70ЊC.
For nuclear and cytoplasmic extracts, tissues were dissected and processed as described previously (10) except that for the cytoplasmic extracts, we omitted the high-speed centrifugation step prior to dialysis. Protein concentrations were determined by the Bradford assay (Bio-Rad, Hercules, Calif.), and aliquots were quickly frozen in liquid N 2 and stored at Ϫ70ЊC.
Fusion proteins. A 1.4-kb SmaI-EcoRI fragment from the Prbp cDNA was gel isolated and subcloned into the pMAL-c2 expression vector (New England BioLabs, Beverly, Mass.). Synthesis of a maltose-binding protein (MBP)-Prbp fusion protein in Escherichia coli DH5␣ was induced with IPTG (isopropyl-␤-Dthiogalactopyranoside) at room temperature. The fusion protein was affinity purified with an amylose resin column, as described by the supplier (New England BioLabs). Fractions containing the fusion protein were aliquoted and stored at Ϫ70ЊC. An MBP-␤-galactosidase (MBP-␤gal) fusion protein was prepared from the pMAL-c2 vector with no insert in a similar manner.
RNA band shift analysis. Labeled RNAs were synthesized in vitro with [␣-
32
P] UTP (3,000 Ci/mmol; NEN-Dupont, Boston, Mass.) by in vitro transcription by a standard protocol (Promega, Madison, Wis.). Full-length products were isolated from nondenaturing polyacrylamide gels as previously described (12a) .
RNA band shift assays were performed as described previously (31 VOL. 16, 1996 A TESTIS CYTOPLASMIC RNA-BINDING PROTEIN 3025 500 ng of fusion proteins or 30 to 50 g of testis extract) for 25 min, the reaction mixture was subject to RNase T 1 digestion (0.5 U; Calbiochem, La Jolla, Calif.) for 10 min. Nonspecific protein binding to RNA probes was minimized by incubating the reaction mixture with heparin at 10 mg/ml. RNA-protein complexes were resolved on a 4% polyacrylamide gel in 0.5ϫ Tris-borate-EDTA at 4ЊC and detected by autoradiography. In the competition band shift assays, the protein extracts were preincubated with unlabeled competitor RNAs for 15 min prior to addition of radiolabeled Prm-1 59-nt RNA. The concentration of poly(I) ⅐ poly(C) (Boehringer Mannheim, Indianapolis, Ind.) RNA was determined by the optical density at 260 nm. Concentrations of cold competitor Prm-1 59-nt RNA were determined by including trace amounts of [ 3 H]UTP in the in vitro run-on transcription reaction and measuring trichloroacetic acid-precipitable incorporated counts.
Antibodies. Rabbit antiserum was raised by immunization with an MBP-Prbp fusion protein, using the services of the R & R Rabbitry (Stanwood, Wash.). An anti-MBP-Prbp antibody was affinity purified by using antigen immobilized on a nitrocellulose filter as described previously (42) .
Western blot (immunoblot) analysis. Total protein (approximately 50 to 150 g) was resolved on SDS-10% polyacrylamide gels that were then electroblotted onto nitrocellulose filters. Blots were blocked with 5% nonfat dry milk in phosphate-buffered saline (BPBS) and then incubated overnight at 4ЊC in the affinitypurified anti-MBP-Prbp antibodies diluted in BPBS. After being washed once in BPBS supplemented with 0.05% Tween 20 and twice in BPBS for 20 min, the blots were incubated with goat anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase (Bio-Rad). After washing as above, the presence of enzyme was revealed by chemiluminescence with luminol and 4-iodophenol as a luminogen as described previously (44) .
Cell-free translation. Capped Prbp mRNA synthesized in vitro from cDNA was translated in a rabbit reticulocyte lysate with [ Immunocytochemistry. Testes and epididymides were dissected from sexually mature males, fixed in Bouin's fixative (0.2% picric acid and 2% paraformaldehyde in 1ϫ PBS) overnight, and embedded in paraffin by standard procedures. Tissue sections were treated with primary antibody as previously described (4). Biotinylated goat anti-rabbit immunoglobulin G and streptavidin conjugated to horseradish peroxidase were used as recommended by the manufacturer (Zymed Laboratories, Inc., South San Francisco, Calif.). Peroxidase activity was visualized with the chromogen aminoethyl carbazole. Tissue sections were counterstained with hematoxylin where indicated. The developmental stage of seminiferous tubules was determined by treating adjacent sections with periodic acidSchiff stain and Harris' hematoxylin as previously described (38, 41) .
In vitro translation inhibition. Synthesized RNA products contained the hGH mRNA fused to either the full-length hGH 3Ј UTR or the full-length Prm-1 3Ј UTR. In vitro transcription reactions were performed in 50-l reaction volumes with 5 g of linearized plasmid template, 0.5 mM ATP, CTP, and UTP, 50 M GTP, 0.5 mM m 7 G(5Ј)ppp(5Ј)G, and 10 Ci of [ Further controls were performed to evaluate translation product proteolysis and RNA template stability in the presence of the MBP-Prbp fusion protein.
MBP-Prbp-induced proteolysis of the hGH translation product was examined by adding 1.0 g of MBP-Prbp fusion protein to a standard translation reaction mixture (0 g of MBP-Prbp fusion protein) following the 2.0 h of incubation at 30ЊC. This sample was incubated for an additional 20 min at 30ЊC prior to SDS-PAGE analysis. The stability of the RNA template in the presence of MBPPrbp was examined as follows. In the same 10-l reaction mixture described above, 1.0 g of MBP-Prbp fusion protein was incubated with 0.25 g of RNA template for 15 min at room temperature; this was followed by phenol and chloroform extraction and RNA recovery via ethanol precipitation. The RNA pellets were resuspended in 10 l of H 2 O, and in vitro translation was performed.
RESULTS

Expression screen. To clone genes that encode potential
Prm-1 translational control factors, we screened lambda gt11 cDNA expression libraries prepared with RNA from pachytene spermatocytes, round spermatids, and mixed germ cells with a 156-nt Prm-1 3Ј UTR RNA probe labeled with digoxigenin as described in Materials and Methods. To enrich for clones that encode Prm-1 RNA-binding proteins and to minimize the number of clones that encode general RNA-binding proteins, only those plaques that upon rescreening did not hybridize with a digoxigenin-labeled 145-nt hGH 3Ј UTR RNA probe were retained for subsequent analysis. Of a total of ϳ7.5 ϫ 10 5 plaques screened, we identified 19 plaques that bound to the Prm-1 3Ј UTR RNA and did not bind, or bound significantly less well, to the hGH 3Ј UTR RNA. Characterization of each of the cDNA clones by DNA cross-hybridization revealed that they represented cDNAs for five different genes. The cDNA from one of these genes, which we refer to as Prbp (for Prm-1 RNA-binding protein), was isolated once from the pachytene spermatocyte library and once from the round spermatid library.
Prbp is a member of a known family of RNA-binding proteins. The largest of the Prbp cDNAs was sequenced and shown to be 1,521 bp long and to contain an open reading frame that would encode a protein of 365 amino acids ( Fig.   FIG. 2. (A) RNA probes used in band shift analysis.
32 P-labeled RNA probes corresponding to the full-length 156-nt Prm-1 3Ј UTR, an 82-nt 5Ј portion, and a 59-nt 3Ј portion were prepared as described in Materials and Methods. Each of the RNAs contained additional sequence contributed by the polylinker sequence contained in the pGEM2 plasmid (Promega), as indicated in 1A). The cDNA contains one in-frame stop codon 72 nt upstream of the putative translation initiation codon, two copies of the polyadenylation signal AATAAA, and a poly(A) tract, suggesting that this cDNA is likely to encode the full-length Prbp protein.
A search of the GenBank database revealed that the Prbp protein has 93% amino acid identity with the human TAR RNA-binding protein (TRBP) (Fig. 1B) , strongly suggesting that Prbp is the mouse homolog of TRBP. TRBP is a cellular protein that was cloned first on the basis of its ability to bind to the human immunodeficiency virus type 1 (HIV-1) TAR RNA in vitro (15) and a second time on the basis of its ability to bind to the HIV-1 Rev-responsive element (39) . Prbp and TRBP contain two copies of a lysine-and arginine-rich motif of 24 amino acids (boxed in Fig. 1B ) that is also found in the human interferon-induced and dsRNA-activated protein kinase, PKR (16) , and in numerous other demonstrated or putative dsRNAbinding proteins (14, 49) .
RNA-binding properties of Prbp. To study the in vitro RNAbinding properties of Prbp, a fusion protein of MBP and Prbp (containing amino acids 28 through 365) was constructed, expressed in E. coli, and affinity purified as described in Materials and Methods. In an RNA band shift assay the MBP-Prbp fusion protein bound to the full-length 156-nt Prm-1 3Ј UTR RNA, producing multiple complexes (Fig. 2B, lane 4) that all migrated more slowly than the free probe (Fig. 2B, lane 1) . A negative control, an affinity-purified fusion protein containing MBP and ␤-galactosidase (MBP-␤gal), failed to bind to the full-length Prm-1 3Ј UTR RNA (Fig. 2B, lane 3) . To determine if Prbp binds to a specific region of the Prm-1 3Ј UTR RNA, band shift assays were performed with an RNA containing 59 nt of the 3Ј-most region, and an RNA containing 82 nt of the 5Ј-most region, of the Prm-1 3Ј UTR (Fig. 2A) . While the 59-nt RNA bound as well as the full-length 156-nt Prm-1 3Ј UTR RNA (Fig. 2B, lane 8) , the 82-nt RNA completely failed to bind to the MBP-Prbp fusion protein (Fig. 2B, lane 12) .
To further map the Prbp-binding site, a series of deletion variants containing different portions of the 3Ј-most region of the 3Ј UTR were constructed and tested in the band shift assay. As summarized in Fig. 3 , the deletion analysis suggested that sequences between nt 107 and 130 (nt 1 being the first nucleotide in the 3Ј UTR) are important for protein binding. To determine if the 24-nt region defined by the deletions is sufficient for MBP-Prbp binding, oligonucleotide-directed in vitro transcription was used to synthesize an RNA containing only the Prm-1-specific 24-nt region and no ribonucleotides contributed by the polylinker sequences in the plasmid vector. RNA band shift analysis revealed that the 24-nt target RNA failed to bind to MBP-Prbp (Fig. 3) , suggesting either that the 24-nt RNA target is too small an RNA for protein binding or that additional sequences on either side of the 24-nt region are required for binding (see Discussion).
As mentioned above, the Prbp protein contains two copies of an amino acid motif found in numerous dsRNA-binding proteins, including the human TRBP protein. To determine if the MBP-Prbp fusion protein binds to dsRNA, competition assays were performed with poly(I) ⅐ poly(C) RNA. Poly(I) ⅐ poly(C) RNA competed for binding of radiolabeled Prm-1 59-nt RNA (Fig. 4B) , as did unlabeled 59-nt Prm-1 RNA (Fig.  4A) , suggesting that, in vitro, Prbp binds dsRNA.
Prbp-binding activity is present in testis cytoplasmic extracts. Protein extracts prepared from mouse testis contain two VOL. 16, 1996 A TESTIS CYTOPLASMIC RNA-BINDING PROTEIN 3027 separate activities that bind to two distinct regions of the Prm-1 3Ј UTR RNA in a band shift assay (2) . One of these activities binds in a sequence-specific manner to a 22-nt site in the 5Ј half of the Prm-1 3Ј UTR (Fig. 5 , lane 2, asterisk) (12a), and the other binds to a 59-nt RNA derived from the 3Ј half of the 3Ј UTR (Fig. 5 , lane 5, closed arrow). To map the binding site for the 3Ј-most binding activity, RNA band shift assays were performed with the same set of Prm-1 3Ј UTR deletion variants previously used to map the MBP-Prbp-binding site. As shown in Fig. 3 , the activity present in testis extracts binds the same set of deletion variants as the MBP-Prbp fusion protein, suggesting that the activity present in testis extracts is Prbp.
To determine if the 3Ј binding activity detected in testis cytoplasmic extracts is Prbp, RNA band shift assays were performed in the presence of a rabbit polyclonal anti-MBP-Prbp antibody prepared as described in Materials and Methods. Addition of the MBP-Prbp antibody to the sample containing the 59-nt probe and the testis cytoplasmic extract (Fig. 5, lane  6) or the MBP-Prbp fusion protein (Fig. 5, lane 8) eliminated the bands previously detected with the testis extract (Fig. 5 , lane 5) and MBP-Prbp alone (Fig. 5, lane 7, arrowheads) and instead resulted in the retention of a significant percentage of the RNA-protein complex in the well (open arrow). Addition of the anti-MBP antibody or preimmune serum to testis cytoplasmic extracts did not affect detection or migration of the complex (data not shown). To confirm that the complex detected with the 5Ј-most 82-nt RNA probe does not contain Prbp and that the anti-MBP-Prbp antibody is binding specifically to the Prbp complex formed with the 59-nt probe, the anti-MBP-Prbp antibody was added to the sample containing the 82-nt probe and the testis cytoplasmic extract. No difference in the mobility of the 5Ј-most complex could be detected in the presence of the anti-MBP-Prbp antibody (Fig. 5 , compare lanes 2 and 3). These data strongly support the conclusion that the Prbp protein is present in testis cytoplasmic extracts and that sequences in the 3Ј-most region of the Prm-1 3Ј UTR RNA are required for binding. In addition, optimal binding of both the testis activity and the MBP-Prbp fusion protein was achieved at approximately 100 mM KCl (data not shown), further supporting the conclusion that the 3Ј-most binding activity is Prbp.
Prbp protein exists in multiple forms in the testis and is expressed only in germ cells. Hybridization of a Western blot containing total and cytoplasmic testis protein extracts with the anti-MBP-Prbp antibody detected a cluster of four major bands around 40 kDa and two minor bands of approximately 35 and 33 kDa (Fig. 6, lanes 3 and 4) . No hybridizing bands were detected in testis nuclear extracts (Fig. 6, lanes 5 and 6) . To determine which of the proteins detected were translation products of Prbp mRNA, Prbp RNA synthesized from the cDNA was in vitro translated in the presence of [ 35 S]methionine with a rabbit reticulocyte lysate, and the products were compared to those identified in the Western blot. All four bands of approximately 40 kDa, as well as the 33-kDa product, were detected as products of the in vitro translation reaction (Fig. 6, lane 2) . Only the minor band of 35 kDa was detected in testis extracts by Western blotting and not by in vitro trans- 1 to 3) or a 59-nt RNA derived from near the 3Ј-end of the Prm-1 3Ј UTR (lanes 4 to 8). The positions of both RNAs are shown schematically in Fig. 3 . Band shift assays were performed with either testis cytoplasmic extracts or the affinity-purified MBP-Prbp fusion protein as indicated above each lane. Following heparin treatment, the samples that were eventually loaded in lanes 3, 6, and 8 were incubated for an additional 30 min with 1 l of an affinity-purified anti-MBP-Prbp antibody (Ab). The asterisk indicates the position of a previously described Prm-1 3Ј UTR-binding activity (12a). The closed arrow indicates the position of the binding activity mapped by using the RNAs shown in Fig. 2 and shown schematically in Fig. 3 lation of Prbp mRNA. The detection of the same quartet of bands of 40 kDa by both Western blotting and in vitro translation of Prbp mRNA suggests that they are all translation products of Prbp mRNA. In addition, hybridization of a Northwestern (RNA-protein) blot containing testis protein extracts with a radiolabeled Prm-1 3Ј UTR RNA probe revealed the same quartet of bands at 40 kDa (data not shown), demonstrating that they can all bind to Prm-1 RNA in vitro. The 33-kDa protein also appears to be a product of Prbp mRNA, but it is likely to be a proteolytic fragment of one of the 40-kDa forms, as its relative abundance varies between testis cell extracts (data not shown).
To determine if Prbp is expressed within the somatic or the germ cell compartment of the testis, Western blot analysis was performed on protein extracts prepared from testes of mouse mutants that either lack germ cells entirely (W/W v [36] ) or contain diploid spermatogonial cells but lack meiotic and postmeiotic germ cells because of an arrest at the beginning of meiosis I (Tfm/Y [32] ). None of the four major Prbp proteins of around 40 kDa, or the minor 33-kDa protein, were detected in extracts prepared from either of the mutants (Fig. 6, lanes 8  and 9) , strongly suggesting that expression of Prbp is restricted to the meiotic and/or postmeiotic germ cells. The 35-kDa protein was detected in W/W v and Tfm/Y testes, suggesting that it is not restricted to germ cells and providing further evidence that it is unlikely to be a product of the Prbp gene. In addition, unlike the 40-kDa protein forms, the 35-kDa protein does not bind the full-length Prm-1 3Ј UTR RNA in Northwestern blot analysis (data not shown).
Developmental expression of Prbp during spermatogenesis. Spermatogenesis occurs within seminiferous tubules and has been described as consisting of 12 stages based on the particular cell associations present in a given tubule, on spermatid nuclear shape, and on the extent of acrosome morphogenesis (38, 41) . Within these 12 stages of the cycle one can describe 16 steps of spermatid differentiation (38) . To determine the stages and cell type in which Prbp is expressed, immunocytochemistry was performed on testis sections by using an anti-MBP-Prbp antibody, and serial sections were stained with hematoxylin (a nuclear stain) and periodic acid-Schiff reagent (an acrosomal stain) (38) . Representative staining of Prbp in a stage II to IV seminiferous tubule is shown in Fig. 7 . The Prbp protein was first detected in stage VII pachytene spermatocytes at a very low level. Prbp was also detected in all later stages of primary and secondary spermatocytes and in haploid spermatids through step 10. Immunostaining appeared to be greatest in round spermatids at step 2 to 3. In all cell types that expressed Prbp, the protein appeared to be localized to the cytoplasm, consistent with our earlier Western blot analysis (Fig. 6) . In summary, the Prbp protein is detected in the cytoplasm of round spermatids through step 10, in which Prm-1 mRNA is repressed, and is not detected in elongated spermatids (steps VOL. 16, 1996 A TESTIS CYTOPLASMIC RNA-BINDING PROTEIN 3029
11 to 16), the cells in which Prm-1 mRNA is translated (1, 24) .
Prbp protein inhibits translation in vitro.
The presence of Prbp in the cytoplasmic compartment of round spermatids, coupled with the ability of testis extracts that contain Prbp to bind to exogenously added Prm-1 3Ј UTR RNA, suggests that Prbp interacts with Prm-1 mRNA in vivo to inhibit its translation. To test the effect of Prbp on mRNA translation, the MBP-Prbp fusion protein was preincubated with either a chimeric message containing the hGH coding sequence fused to the Prm-1 3Ј UTR or an hGH mRNA containing its normal 3Ј UTR and was translated in a wheat germ cell-free translation lysate. Dose-response experiments revealed that both messages, the Prm-1 3Ј UTR-containing message and the hGH 3Ј UTR-containing message, were sensitive to inhibition in the presence of MBP-Prbp ( Fig. 8A and B, lanes 1 to 4, and Fig.  8C ). This inhibitory effect was also observed in a reticulocyte lysate (data not shown). Translation was not significantly inhibited in the presence of MBP alone ( Fig. 8A and B, lanes 5; Fig. 8C , MBP) or in protein storage buffer alone (data not shown). These results suggest that Prbp is capable of inhibiting translation in vitro but that it is not specific to mRNAs containing the Prm-1 3Ј UTR. The stability of the newly synthesized hGH protein product was not markedly affected by incubation with the MBP-Prbp fusion protein following the translation reaction ( Fig. 8A and B, lanes 6; Fig. 8C, Post) , suggesting that the MBP-Prbp fusion protein does not cause protein proteolysis. Induced instability of the reporter mRNAs was not accountable for the reduced amount of hGH protein product observed in the presence of the MBP-Prbp fusion protein.
Reporter mRNA extracted from a sample preincubated with MBP-Prbp produced nearly the same amounts of hGH protein product as untreated mRNA (Fig. 8A and B, lanes 7; Fig. 8C, RE) . RNA losses sustained during the extraction protocol probably account for the reduced amount of hGH detected in this control. Thus, Prbp protein can inhibit translation in vitro, but it does so in a nonspecific manner. Tissue distribution of Prbp mRNA and protein. Hybridization of a Northern blot containing total RNA prepared from various adult mouse tissues with the radiolabeled Prbp cDNA revealed a single transcript of approximately 1.6 kb that is present at high levels in the testis and at low but detectable levels in numerous other tissues (Fig. 9A) . Surprisingly, hybridization of a Western blot containing total protein extracts prepared from adult mouse tissues with anti-MBP-Prbp antibody failed to detect the cluster of the four major Prbp bands around 40 kDa, and the minor band of approximately 33 kDa, in any tissue except the testis (Fig. 9B) . We did, however, detect the cross-reacting band of 35 kDa in all of the extracts and a minor band of approximately 80 kDa in the spleen and ovary. These results suggest that, despite the presence of Prbp mRNA in all tissues tested, Prbp protein either is not expressed or is below our limit of detection in any tissue except the testis.
DISCUSSION
The properties of the Prbp protein described in this paper suggest that it has a role in the translational repression of Prm-1 mRNA. First, the temporal and spatial patterns of Prbp expression are those expected for an inhibitor of Prm-1 translation. Prbp protein is abundant in the testis and is localized in the cytoplasmic compartment of round spermatids, where translation of Prm-1 mRNA is repressed, but it is not detected in elongated spermatids, where Prm-1 mRNA is translated. Second, both recombinant and testis-derived Prbp proteins bind to a region contained in the 3Ј-most 62 nt of the Prm-1 3Ј UTR mRNA. This region is sufficient for translational repression of a heterologous mRNA in transgenic mice (3) and is the region most highly conserved between the 3Ј UTRs of mouse Prm-1 and Prm-2 (20) . This sequence is also highly conserved in the bovine (27) and human (29) Prm-1 3Ј UTRs. Third, translation of a reporter mRNA is inhibited in a cell-free lysate in the presence of Prbp protein, although inhibition is not dependent on the Prm-1 3Ј UTR.
The numerous properties of Prbp just described are consistent with, but do not prove, the hypothesis that Prbp functions as a translational repressor of Prm-1 mRNA in spermatids. Although Prbp binds to the most conserved region of the Prm-1 3Ј UTR, it also binds to poly(I) ⅐ poly(C), suggesting that it may be recognizing a highly structured region within the Prm-1 3Ј UTR and that it may interact with mRNAs other than Prm-1 mRNA in vivo. Consistent with its ability to bind to poly(I) ⅐ poly(C), Prbp contains two copies of a previously described dsRNA-binding motif (14, 49) . Despite the apparent nonspecific binding properties of these proteins in vitro, genetic studies suggest that at least some of the members of this family interact with selected mRNAs in vivo (11-13, 22, 48) . We presume that, in vivo, additional factors may facilitate specific interactions between the Prbp protein and its target mRNAs, such as Prm-1.
Developmental expression of Prbp parallels that of Prm-1 translational repression. The Prbp gene is transcribed at high levels in the testis, and by Western blotting analysis we were VOL. 16, 1996 A TESTIS CYTOPLASMIC RNA-BINDING PROTEIN 3031 able to detect a collection of proteins migrating at approximately 40 kDa. Analysis of the in vitro translation products of Prbp mRNA supports the conclusion that the different proteins are all translation products of Prbp mRNA. The different sizes of Prbp may result from posttranslational modifications of a single translation products, or they may be amino-terminal truncations derived from alternative translational start sites. The latter possibility seems most likely given the existence of one additional in-frame AUG codon, and two CUG codons, positioned slightly downstream of the putative initiator AUG (Fig. 1A) .
Despite the fact that we were able to detect low levels of Prbp mRNA in various adult tissues analyzed, we were unable to detect any of the 40-kDa forms of Prbp protein by Western blotting in extracts prepared from those same tissues. These data suggest that expression of Prbp protein is restricted to germ cells or that the level of Prbp protein in somatic adult tissues is below our limit of detection. A common band of approximately 35 kDa was detected in tissues other than the testis; however, because we were unable to detect this band in vitro following translation of Prbp mRNA prepared from Prbp cDNA, we conclude that the 35-kDa protein is not encoded by Prbp.
Genetic, biochemical, and immunocytochemical evidence supports the conclusion that Prbp protein is expressed in latestage pachytene spermatocytes and round spermatids. We were unable to detect Prbp protein by Western blot analysis in testis extracts prepared from mouse mutants that either lack germ cells entirely (W/W v ) or contain diploid germ cells but lack meiotic and postmeiotic germ cells (Tfm/Y), suggesting that Prbp is expressed in germ cells and not in the somatic cells of the testis. Furthermore, immunocytochemical localization of Prbp in testis sections from normal mice showed that Prbp is present at low levels in stage VII pachytene spermatocytes, is abundant in round spermatids, and remains detectable through step 10. Prbp is localized to the cytoplasm in all of these cell types, and many mRNAs are under translational control during this phase of spermiogenesis. The temporal expression and spatial localization of Prbp are consistent with it functioning as a general translational repressor during this period.
Prbp is the mouse homolog of human TRBP. Sequence analysis showed that Prbp is a member of a rapidly growing family of proteins which share a common RNA-binding motif (14, 49) . This family includes human TRBP (15), human interferon-inducible and dsRNA-activated protein kinase (referred to as p68, DAI, and PKR) (16) , Drosophila staufen (48) , and the murine Tenr (45) and Spnr (46) proteins, the products of two other genes identified in our expression screen. The Prbp protein contains two copies of the RNA-binding motif that defines this family of proteins.
Prbp is striking in its similarity (93% identical at the amino acid level) to human TRBP (Fig. 1B) and is most likely its mouse homolog. The TRBP gene was originally cloned from a HeLa cell cDNA expression library on the basis of its ability to bind to the HIV-1 TAR RNA in vitro (15) and was cloned a second time on the basis of its ability to bind to the HIV-1 Rev-responsive element (39) . The function of TRBP in noninfected cells is unknown, although it has been suggested that TRBP may act as an inhibitor of the interferon-induced protein kinase, PKR, and in doing so indirectly control protein ) were resolved on SDS-10% polyacrylamide gels that were then electroblotted onto a nitrocellulose filter as described in Materials and Methods. The filter was incubated overnight at 4ЊC in the affinity-purified anti-MBP-Prbp antibody. After being washed, the blot was incubated with goat anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase, and the presence of enzyme was revealed by chemiluminescence with luminol and 4-iodophenol as a luminogen as described previously (44) . Protein size markers are indicated on the right.
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synthesis (39) . In support of this, TRBP has been shown to interact with PKR in the two-hybrid system and by far-Western (protein-protein) blotting (7), although in both cases it may be doing so by binding to a common RNA. Our data do not address the possible function of Prbp as a regulator of the murine PKR. However, in vitro, the RNA-binding properties of Prbp and TRBP appear to be quite similar. One difference between our data on Prbp and those reported for TRBP is that we find that in the testis Prbp is cytoplasmic. This was shown by both Western blotting and immunocytochemistry. In contrast, in HeLa cells TRBP has been shown to be primarily nuclear (26) . In the future it will be important to determine if TRBP is expressed during spermatogenesis in humans, if it is localized in the cytoplasm, and if TRBP interacts with the 3Ј UTR of human Prm-1 RNA. RNA binding in vitro. In vitro RNA-binding studies showed that Prbp binds to a specific region of the Prm-1 3Ј UTR. In the band shift assay that we used, Prbp either bound the substrate RNA completely or failed to bind at all, suggesting that a binding site is present within the 3Ј-most region of the Prm-1 3Ј UTR. We do not know if sequence and/or structure is important for binding of Prbp to the Prm-1 3Ј UTR. However, competition assays performed with poly(I) ⅐ poly(C) suggest that, in vitro, Prbp binds to dsRNA nonspecifically. Although there are no extensive regions of potential base pairing in the Prm-1 3Ј UTR, there are two alternate stem-loop structures that could theoretically form and be stabilized by protein binding (Fig. 10A) .
While deletion analyses suggest that sequences contained within a 24-nt region in the 3Ј-most region of the Prm-1 3Ј UTR are important for Prbp binding (Fig. 3 and 10A , nt 107 to 130), attempts to detect binding to an RNA that contains only the 24-nt sequence were unsuccessful. This result can be explained in two different ways. First, the 24-nt RNA may contain all of the binding specificity for Prbp binding but may not be of sufficient length for binding. Support for this possibility comes from studies with PKR, which have shown that a minimum target of 30 bp of dsRNA is required for binding (35) . Second, sequences flanking the 24-nt region may constitute part of the binding site. Sequences that flank the 24 nt that may be important are two nearly perfect 17-nt repeats (Fig. 10B) . Each repeat is capable of base pairing with a sequence between the repeats (nt 105 to 115) to form a region of dsRNA. In this scenario, RNAs extending from nt 72 to 130 or from nt 107 to 156 can base pair to form similar stem-loop structures (Fig. 10A) . In contrast, an RNA that contained only the 24-nt region defined by deletion analysis (nt 107 to 130) would not form either structure, nor would an RNA extending from nt 121 to 156 (Fig. 3) . Clearly, additional mutational analysis is required to distinguish between the roles of sequence and structure in Prbp binding.
Another feature of Prbp binding is its tendency to form oligomers (Fig. 2B) . This feature has also been reported for TRBP (14) and PKR (35) , as well as for proteins of other families of RNA-binding proteins, including the Rev protein of HIV-1 (6, 17, 34, 53) and the Xenopus Y box protein (50) . In the case of the Rev protein, oligomerization seems to be essential for RNA binding, although this has been challenged by others (6, 34) . At high protein concentrations, Rev protein binds to RNA and nucleates the assembly of long filamentous ribonucleoprotein structures (17) . The oligomerization of the Rev protein also seems to be important for in vivo Rev function because Rev mutants defective in oligomerization but not in RNA binding lack biological activity (34) .
Given that Prbp is capable of protecting large regions of RNA from RNase digestion in vitro (29b) and that it can form oligomers in vitro, it is easy to imagine a simple model for translational repression in which Prbp first binds to a specific site in the 3Ј UTR of Prm-1 RNA and then oligomerizes to form a filamentous ribonucleoprotein particle that is translationally inactive. (27) and human (28) Prm-1 3Ј UTRs and is the region most highly conserved between the 3Ј UTRs of mouse Prm-1 and Prm-2 (referred to as the Z box [20] ). As shown in panel A, either repeat is able to base pair with another region of the Prm-1 3Ј UTR (located between nt 105 and 115) and form a region of dsRNA with a similarly sized single-stranded loop.
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